PBH FY 2013 Earnings Report — Prestige Consumer Healthcare Inc. Revenue & Financial Results | Market Cap Arena

Prestige Consumer Healthcare Inc.PBH

FY 2013 Earnings

Reported May 17, 2013

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2013	Prior Q	FY 2012	QoQ Change	YoY Change
Revenue	$624M	—	$441M	—	41.4%
Op. Income	$192M	—	$103M	—	86.6%
Gross Margin	55.7%	—	51.6%	—	4.1pp
Net Margin	10.5%	—	8.4%	—	2.1pp
EPS (Diluted)	$1.27	—	$0.73	—	74.0%
Free Cash Flow	$127M	—	$67M	—	90.5%

Revenue Flow

Item	Amount
REVENUE	$624M
Cost of Revenue	$276M
GROSS PROFIT	$347M
R&D Expenses	$0
Selling & Marketing	$91M
General & Administrative	$51M
SG&A Expenses	$142M
Other Expenses	$13M
Operating Expenses	$155M
Cost & Expenses	$432M
OPERATING INCOME	$192M
Interest Income	$13.0K
Interest Expense	$84M
Other Income/Expenses	-$86M
INCOME BEFORE TAX	$106M
Income Tax Expense	$41M
Net Income from Continuing Ops	$66M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$66M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$66M
D&A	$13M
EBIT	$190M
EBITDA	$204M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$624M
Cost of Revenue	$276M
GROSS PROFIT	$347M
R&D Expenses	$0
Selling & Marketing	$91M
General & Administrative	$51M
SG&A Expenses	$142M
Other Expenses	$13M
Operating Expenses	$155M
Cost & Expenses	$432M
OPERATING INCOME	$192M
Interest Income	$13.0K
Interest Expense	$84M
Other Income/Expenses	-$86M
INCOME BEFORE TAX	$106M
Income Tax Expense	$41M
Net Income from Continuing Ops	$66M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$66M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$66M
D&A	$13M
EBIT	$190M
EBITDA	$204M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$66M
Depreciation & Amortization	$13M
Stock-Based Compensation	$4M
Deferred Income Tax	$26M
Other Non-Cash Items	$17M
Change in Working Capital	$13M
OPERATING CASH FLOW	$138M
Capital Expenditure	-$10M
Acquisitions (Net)	$21M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$15.0K
NET CASH FROM INVESTING	$11M
Net Debt Issuance	-$158M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$6M
NET CASH FROM FINANCING	-$152M
FREE CASH FLOW	$127M
Net Change in Cash	-$3M

Balance Sheet

Item	Amount
Cash & Equivalents	$16M
Short-Term Investments	$0
Net Receivables	$73M
Inventory	$60M
Other Current Assets	$6M
TOTAL CURRENT ASSETS	$164M
PP&E (Net)	$10M
Goodwill	$168M
Intangible Assets	$1.4B
Long-Term Investments	-$6M
Tax Assets	$6M
Other Non-Current Assets	$25M
TOTAL NON-CURRENT ASSETS	$1.6B
TOTAL ASSETS	$1.7B
Account Payables	$51M
Short-Term Debt	$0
Deferred Revenue	$0
Other Current Liabilities	$36M
TOTAL CURRENT LIABILITIES	$97M
Long-Term Debt	$971M
Deferred Revenue NC	-$194M
Deferred Tax Liabilities	$194M
Other Non-Current Liabilities	$0
TOTAL NON-CURRENT LIABILITIES	$1.2B
TOTAL LIABILITIES	$1.3B
Common Stock	$513.0K
Additional Paid-In Capital	$402M
Retained Earnings	$76M
Treasury Stock	-$687.0K
Accum. Other Comp. Income	-$104.0K
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$478M
Minority Interest	$0
TOTAL EQUITY	$478M
TOTAL LIABILITIES & EQUITY	$1.7B
Total Debt	$971M
Net Debt	$955M